Waters announces US FDA 510(k) clearance of BD BACTEC FXI Culture System
Singapore, June 4 -- Waters Corporation has announced that the BD BACTEC FXI Culture System has received US Food and Drug Administration (FDA) 510(k) clearance. This clearance enables commercialisation in the US and provides a new option for laboratories seeking a fully automated blood culture system designed to improve the speed, consistency, and accuracy of sepsis and bloodstream infection diagnostics in modern microbiology laboratories.
The BD BACTEC FXI Culture System features a first-of-its-kind capability in a blood culture platform - an automated gravimetric measurement of individual blood culture vial volume. By objectively confirming blood volume in each vial, the system reduces pre-analytical variability and supports more consi...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.